Abstract:The Asian Alzheimer's disease (AD) instrument validation study is designed to assess if the major AD instruments developed in western countries are valid and reliable for use among the Asian AD population. The report here is the result of the first interim analysis. This is a multicenter, longitudinal, non-interventional study including five Asian countries/regions. The instruments included ADAS-Cog, DAD, Neuropsychological Test Battery (NTB), CDR, MMSE and Dependence Scale (DS). Study method was previously described in detail (poster 16402, AAICAD 2011). 302 participants (251AD patients, 51 healthy controls) were enrolled for the study. Screening and baseline data were analyzed here. The mean age of participants was 71 years (range: 50-85). Over half of participants were female (57%). Most participants were married (83%) and living with a spouse (71%). 32% of the subjects had at least some college education. The nationality of participants generally aligned with the region of their enrolment. Healthy controls showed better cognitive functioning than AD subjects (P<.05) with magnitude varying across the specific neuropsychological tests. Overall, minimal ceiling effect was found for AD subjects across various tests while ceiling effect was found for health y control for many tests. For AD participants, test-retest reliability was confirmed with ICC > 0.7 for 17 of 19 tests. Non-NTB tests were significantly (P< 0.05) correlated with each other and with NTB component, summary and total scores, supporting convergent and divergent validity. Greater disease severity corresponded to significantly (P< 0.003) poorer performance on nearly every assessment, supporting discriminant validity. ApoE4 was detected in 85 of 210 (40.5%) AD patients and 5 of 36 (13.9%) healthy controls (P=0.002). ApoE4 was detected in 44 (40.7%) with mild AD and 41 (40.2%) with moderate/severe AD. There were no significant differences among ApoE4 carriers and non-carriers on instrument scores. This study is the first to evaluate the psychometric properties of multiple AD instruments in five Asian countries/regions. These promising results support the initial psychometric properties of these instruments, enabling their use in Chinese, Korean, and English-speaking AD population in a psychometrically sound manner. Data collection is on-going to evaluate their responsiveness over time.

Diagnostic Schedules for Mental Disorders field trials for patients with AIzheimer disease

Reliability and Validity of the International Dementia Alliance Schedule for the Assessment and Staging of Care in China

The Discriminant Validity of Single-Question Assessments of Subjective Cognitive Complaints in an Asian Older Adult Population.

The cognitive subscale of Alzheimer's Disease Assessment Scale, Chinese version in staging of Alzheimer disease.

The Diagnostic Framework for Screening Alzheimer's Disease in the Chinese Population

Validity and Reliability of Chinese Version of Alzheimer's Disease Assessment Scale

[Screening and Diagnostic Framework of Vascular Dementia in Chinese Population].

Application of the IWG-2 Diagnostic Criteria for Alzheimer’s Disease to the ADNI

Discriminatory Potential of the Chinese Version of ADAS-Cog for Mild Versus Moderate Alzheimer Disease

Estimation of diagnostic performance of dementia screening tests: Mini-Mental State Examination, Mini-Cog, Clock Drawing test and Ascertain Dementia 8 questionnaire.

Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer's Disease.

Performance of Mattis Dementia Rating Scale-Chinese Version in Patients with Mild Cognitive Impairment and Alzheimer's Disease

Clinical and Research Value of the New Diagnostic Criteria for Alzheimer's Disease.

S3‐03‐04: Prevalence Study in Shanghai

P4‐170: Alzheimer's Disease Instrument Validation Study in Asia

Alzheimer's Disease Instruments Validation Study in Asia

A Mobile Interactive Cognitive Self-Assessment Scale for Screening Alzheimer’s Disease

Distinguishing the clinical and psychological characteristics between patients with amnestic mild cognitive impairment and very mild Alzheimer disease

Distribution of Baseline Scores of the Alzheimer's Disease Assessment Scale-Cognitive Subscale among the Elderly in Beijing

Cognitive Abilities Screening Instrument-Chinese Revised Version in Participants with Mild Cognitive Impairment and Alzheimer's Disease

Evaluation of Various Memory Tests for Diagnosis of Alzheimer's Disease